Related references
Note: Only part of the references are listed.Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis
Robert R. Quinn et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Policy Monitor How US Government Agencies Value Mortality Risk Reductions
Lisa A. Robinson
REVIEW OF ENVIRONMENTAL ECONOMICS AND POLICY (2007)
Mortality-risk Valuation and Age: Stated Preference Evidence
Alan Krupnick
REVIEW OF ENVIRONMENTAL ECONOMICS AND POLICY (2007)
Age Differences in the Value of Statistical Life: Revealed Preference Evidence
Joseph E. Aldy et al.
REVIEW OF ENVIRONMENTAL ECONOMICS AND POLICY (2007)
Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis
Bas Groot Koerkamp et al.
MEDICAL DECISION MAKING (2007)
Seeing the nice side of cost-effectiveness analysis: A qualitative investigation of the use of CEA in nice technology appraisals
Stirling Bryan et al.
HEALTH ECONOMICS (2007)
The value of coronary heart disease care for the elderly: 1987-2002
Allison B. Rosen et al.
HEALTH AFFAIRS (2007)
Calculating QALYs, comparing QALY and DALY calculations
Franco Sassi
HEALTH POLICY AND PLANNING (2006)
Valuing avoided morbidity using meta-regression analysis: what can health status measures and QALYs tell us about WTP?
George Van Houtven et al.
HEALTH ECONOMICS (2006)
Yes No or Yes, but? Multinomial modelling of NICE decision-making
Helen Angela Dakin et al.
HEALTH POLICY (2006)
Priorities among effective clinical preventive services - Results of a systematic review and analysis
Michael V. Maciosek et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2006)
Priorities among effective clinical preventive services - Methods
Michael V. Maciosek et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2006)
An empirical Bayes approach to combining and comparing estimates of the value of a statistical life for environmental policy analysis
Ikuho Kochi et al.
ENVIRONMENTAL & RESOURCE ECONOMICS (2006)
Incremental cost-effectiveness ratios (ICERs): The silence of the lambda
A Gafni et al.
SOCIAL SCIENCE & MEDICINE (2006)
Bias in published cost effectiveness studies: systematic review
CM Bell et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Measuring the value of a statistical life: Problems and prospects
O Ashenfelter
ECONOMIC JOURNAL (2006)
Economic evaluation and decision making in the UK
Martin J. Buxton
PHARMACOECONOMICS (2006)
Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis
MM Byrne et al.
MEDICAL DECISION MAKING (2005)
Willingness to pay for a quality-adjusted life year: Implications for societal health care resource allocation
JT King et al.
MEDICAL DECISION MAKING (2005)
Reevaluating the benefits of folic acid fortification in the United States: Economic analysis, regulation, and public health
SD Grosse et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2005)
Can we estimate the 'social' value of a QALY? Four core issues to resolve
RD Smith et al.
HEALTH POLICY (2005)
Implicit versus explicit ranking: On inferring ordinal preferences for health care programmes based on differences in willingness-to-pay
JA Olsen et al.
JOURNAL OF HEALTH ECONOMICS (2005)
Quality-adjusted life years was a poor predictor of women's willingness to pay in acute and chronic conditions: results of a survey
DM Franic et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2005)
QALY maximisation and people's preferences: a methodological review of the literature
P Dolan et al.
HEALTH ECONOMICS (2005)
Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis
N Devlin et al.
HEALTH ECONOMICS (2004)
When does quality-adjusting life-years matter in cost-effectiveness analysis?
RH Chapman et al.
HEALTH ECONOMICS (2004)
The impact of information on non-health attributes on willingness to pay for multiple health care programmes
C Protière et al.
SOCIAL SCIENCE & MEDICINE (2004)
Use of cost-effectiveness analysis in health-care resource allocation decision-making:: How are cost-effectiveness thresholds expected to emerge?
HG Eichler et al.
VALUE IN HEALTH (2004)
Cost-effectiveness versus cost-utility analysis of interventions for cancer: Does adjusting for health-related quality of life really matter?
TO Tengs
VALUE IN HEALTH (2004)
Incorporating recipient choice in kidney transplantation
XM Su et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Prioritizing health care: Is health always an appropriate maximand?
A Oliver
MEDICAL DECISION MAKING (2004)
Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States
DA Marshall et al.
VOX SANGUINIS (2004)
The value of a statistical life: A critical review of market estimates throughout the world
WK Viscusi et al.
JOURNAL OF RISK AND UNCERTAINTY (2003)
A utility-theoretic model for QALYs and willingness to pay
T Klose
HEALTH ECONOMICS (2003)
QALYs versus WTP
JK Hammitt
RISK ANALYSIS (2002)
Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis?
P Dolan et al.
JOURNAL OF HEALTH ECONOMICS (2002)
Assessing preferences for prevention versus treatment using willingness to pay
PS Corso et al.
MEDICAL DECISION MAKING (2002)
Pharmaco-economics of blood transfusion safety: review of the available evidence
M van Hulst et al.
VOX SANGUINIS (2002)
Is there a kink in consumers' threshold value for cost-effectiveness in health care?
BJ O'Brien et al.
HEALTH ECONOMICS (2002)
National Institute for Clinical Excellence (NICE): Is economic appraisal working?
A Towse et al.
PHARMACOECONOMICS (2002)
Health state values from multiattribute utility instruments need correction
E Nord
ANNALS OF MEDICINE (2001)
Publishing web-based guidelines using interactive decision models
GD Sanders et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2001)
Cost effectiveness analysis and the consistency of decision making - Evidence from pharmaceutical reimbursement in Australia (1991 to 1996)
B George et al.
PHARMACOECONOMICS (2001)
Cost-utility analyses of clinical preventive services - Published ratios, 1976-1997
PW Stone et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2000)
Economic evaluation and end-stage renal disease: From basics to bedside
BJ Manns et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
Willingness to pay for a quality-adjusted life year: In search of a standard
RA Hirth et al.
MEDICAL DECISION MAKING (2000)
Universal versus targeted screening of infants for sickle cell disease: A cost-effectiveness analysis
JA Panepinto et al.
JOURNAL OF PEDIATRICS (2000)
Improving value measurement in cost-effectiveness analysis
PA Ubel et al.
MEDICAL CARE (2000)
Are pharmaceuticals cost-effective? A review of the evidence
PJ Neumann et al.
HEALTH AFFAIRS (2000)
Share Paper
